[Significance in phlebology of a spray dermatologic cream].
D000336:Aerosols / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D004304:Dosage Forms; D004349:Drug Packaging; D004485:Eczema / Q000188:drug therapy*; D005601:Framycetin / Q000627:therapeutic use*; D006484:Hemorrhoids / Q000188:drug therapy; D006801:Humans; D009761:Nystatin / Q000627:therapeutic use*; D011537:Pruritus / Q000188:drug therapy; D014449:Tyrothricin / Q000627:therapeutic use*; D014647:Varicose Ulcer / Q000188:drug therapy*
D000336:Aerosols; D003879:Dermatologic Agents; D004304:Dosage Forms; D009761:Nystatin; D014449:Tyrothricin; D005601:Framycetin; D003907:Dexamethasone
Intérêt en phlébologie d'un crème dermatologique pulvérisée.